Ecovyst earnings release, August 5, 2026

Ecovyst Inc. (ECVT) · Form 8-K, Item 2.02 · Filed · SEC filing

Ecovyst Reports Second Quarter 2026 Results and Raises 2026 Outlook

WAYNE, PA, August 5, 2026

-- Ecovyst Inc. (NYSE: ECVT) (“Ecovyst” or the “Company”), a leading provider of regenerated sulfuric acid, virgin sulfuric acid, and sulfur dioxide and related derivatives, today reported results for the second quarter ended June 30, 2026.

On December 31, 2025, the Company completed the sale of its Advanced Materials & Catalysts business, which includes the Company’s investment in affiliated companies, Zeolyst International and Zeolyst C.V. Financial results of the divested Advanced Materials & Catalysts business are reported in discontinued operations in the financial statements for all periods presented.

Second Quarter 2026 Results & Highlights from Continuing Operations

• Sales grew 42% to $250.0 million, an increase of $73.9 million, from $176.1 million in the second quarter of 2025

• Net income of $10.7 million, compared to $5.0 million in the year-ago quarter, with a net income margin of 4.3% and diluted net income per share of $0.10

• Adjusted Net Income was $23.4 million, compared to $11.4 million in the year-ago quarter, with Adjusted Diluted Income per share of $0.21

• Adjusted EBITDA grew 27% to $53.1 million, an increase of $11.2 million from $41.9 million in the second quarter of 2025

• Cash flow from operating activities was $55.2 million for the six months ended June 30, 2026, compared to $25.3 million for the six months ended June 30, 2025. Adjusted Free Cash Flow was $12.8 million for the six months ended June 30, 2026, compared to $(2.4) million for the six months ended June 30, 2025

• Completed the strategic acquisition of the Calabrian sulfur dioxide and related derivatives business from INEOS Enterprises on June 30, 2026

“In the second quarter of 2026 Ecovyst continued to deliver on its financial and long-term strategic objectives. As anticipated, high refinery utilization and positive alkylate economics contributed to increased volume of regenerated sulfuric acid, while virgin sulfuric acid volume increased double digits, reflecting positive demand fundamentals and the contribution from the Waggaman sulfuric acid plant we acquired in May 2025. As a result, we delivered second quarter 2026 Adjusted EBITDA of $53 million, within our guidance range, and up 27% compared to the year ago quarter,” said Kurt J. Bitting, Ecovyst’s Chief Executive Officer.

“We remain focused on creating long-term stockholder value by delivering differentiated growth by capitalizing on favorable trends in our end-use segments and pursuing synergistic acquisitions that expand our ability to serve those attractive industries,” said Bitting. “In Q2 2026, we completed our acquisition of the Calabrian sulfur dioxide and related derivatives business. This transaction broadens Ecovyst’s platform of leading sulfur-based solutions, expands our presence in core applications such as mining and water treatment, and provides us with attractive growth opportunities in adjacent industry applications such as food processing and pharmaceuticals. As we begin the integration of Calabrian into Ecovyst, we expect to realize meaningful synergies that we believe will create additional value for our stockholders,” said Bitting. “Based upon our favorable results for the first six months of the year, and to reflect the anticipated financial contribution of Calabrian in the second half of the year, we are raising our guidance for full-year Adjusted EBITDA to a range of $195 million to $207 million,” added Bitting.

Review of Business Results

Second quarter 2026 sales were $250.0 million, up $73.9 million or 42%, compared to $176.1 million in the second quarter of 2025. The increase in sales reflects higher sales volume and pricing compared to the prior year quarter. Average selling prices were higher primarily due to the pass-through effect of higher sulfur costs of approximately $55 million and favorable contractual pricing for regenerated sulfuric acid. The increase in sales volume was driven by higher sales of regenerated sulfuric acid from strong demand and less customer downtime, along with higher sales of virgin sulfuric acid due to increased customer demand and the contribution of sales volume from the Waggaman location, compared to the prior year quarter. Second quarter 2026 Adjusted EBITDA was $53.1 million, up $11.2 million or 27%, compared to $41.9 million in the second quarter of 2025, with the increase primarily driven by higher sales volume and favorable net pricing, partially offset by higher manufacturing costs, general inflation and higher transportation costs.

Cash Flows and Balance Sheet

Cash flows from operating activities for continuing operations were

$55.2 million for the six months ended June 30, 2026, co mpared to $25.3 million for the six months ended June 30, 2025. The increase was primarily driven by higher earnings exclusive of non-cash expenses.

As of June 30, 2026, the Company had cash and cash equivalents of $87.8 million. Total gross debt was $497.1 million and availability under the Asset-Based Lending (“ABL”) facility was $88.5 million, after giving effect to $2.2 million of outstanding letters of credit and with no revolving credit facility borrowings outstanding. Total cash and cash equivalents of $87.8 million plus the $88.5 million of availability under the ABL facility provided for total available liquidity of $176.3 million.

As of June 30, 2026, the net debt to net income ratio was 15.9x and the net debt leverage ratio was 2.0x. The increase in the net debt leverage ratio from 1.2x at December 31, 2025 is due to the $100 million increase in the term loan associated with the acquisition of the Calabrian business with no associated Adjusted EBITDA in the trailing twelve-month period related to the Calabrian business.

Revised 2026 Financial Outlook... (truncated)t strong demand for regenerated acid to support alkylate production and lower customer downtime, compared to the second half of 2025. However, and consistent with our previous guidance, we expect lower sales of virgin sulfuric acid in the third and fourth quarters, compared to 2025, primarily reflecting lower expected spot sales opportunities. We remain cautious about the potential for softer demand in some industrial applications for virgin sulfuric acid.

In light of the acquisition of the Calabrian sulfur dioxide and related derivatives business on June 30, 2026, we are revising our consolidated full-year 2026 guidance to reflect our expectations for Calabrian’s contributions in the third and fourth quarters of 2026.

The Company’s revised 2026 guidance is as follows:

▪ Sales¹ of $1,020 million to $1,060 million (change from $890 million to $970 million)

▪ Adjusted EBITDA² of approximately $195 million to $207 million (change from $180 million to $195 million), including an impact from Calabrian in the second half of 2026 of $10 million to $12 million

▪ Adjusted Free Cash Flow² of $45 million to $55 million (change from $40 million to $55 million)

▪ Capital expenditures of $85 million to $95 million (change from $80 million to $90 million)

▪ Interest expense of $18 million to $22 million

▪ Depreciation & Amortization of $80 million to $84 million (change from $78 million to $82 million)

▪ Effective tax rate in the mid 20% range

▪ Adjusted Net Income² of $65 million to $85 million (change from $55 million to $75 million), with Adjusted Diluted Income per share² of $0.58 to $0.72 (change from $0.50 to $0.65)¹

Sales outlook for 2026 assumes higher average sulfur prices compared to 2025 and higher projected pass-through of sulfur costs of approximately $220 million (change from approximately $155 million).²

In reliance upon the unreasonable efforts exemption provided under Item 10(e)(1)(i)(B) of Regulation S-K, the Company is not able to provide a reconciliation of its non-GAAP financial guidance to the corresponding GAAP measures without unreasonable effort because of the inherent difficulty in forecasting and quantifying certain amounts necessary for such a reconciliation such as certain non-cash, nonrecurring or other items that are included in net income and net cash provided by operating activities as well as the related tax impacts of these items and asset dispositions / acquisitions and changes in foreign currency exchange rates that are included in cash flow, due to the uncertainty and variability of the nature and amount of these future charges and costs. Because this information is uncertain, the Company is unable to address the probable significance of the unavailable information, which could be material to future results.

Stock Repurchase

In April 2022, the Company’s Board of Directors approved a stock repurchase program authorizing the repurchase of up to $450 million of the Company’s outstanding common stock. In October 2025, the Company’s Board of Directors approved the removal of the expiration date of the stock repurchase program. As of June 30, 2026, $146.5 million was available for stock repurchases under the program.

During the second quarter of 2026, the Company did not repurchase any shares of its common stock pursuant to the stock repurchase program. For the six months ended June 30, 2026, the Company repurchased 3,226,461 shares of its common stock on the open market at an average price of $11.07 per share, for a total cost of $35.7 million.

During the second quarter of 2025, the Company repurchased 2,926,152 shares of its common stock on the open market at an average price of $7.47 per share, for a total cost of $21.9 million.

For possible future repurchases, the actual timing, number, and nature of shares repurchased will depend on a variety of factors, including stock price, trading volume, and general business and market conditions and may be conducted through negotiated transactions, open market repurchases or other means, including through Rule 10b-18 and Rule 10b5-1 trading plans or accelerated stock repurchases. The repurchase program does not obligate the Company to acquire any number of shares in any specific period, or at all, and the repurchase program may be amended, suspended or discontinued at any time at the Company’s discretion.

Conference Call and Webcast Details

On Wednesday, August 5, 2026, Ecovyst management will review the second quarter 2026 results during a conference call and audio-only webcast scheduled for 11:00 a.m. Eastern Time.

Conference Call: Investors may listen to the conference call live via telephone by dialing

1 (800) 245-3047

(domestic) or

1 (203) 518-9765

(international) and use the participant code ECVTQ226.

Webcast: An audio-only live webcast of the conference call and presentation materials can be accessed at https://investor.ecovyst.com. A replay of the conference call/webcast will be made available at https://investor.ecovyst.com/events-presentations.

Investor Contact:

Gene Shiels

(484) 617-1225 gene.shiels@ecovyst.com

About Ecovyst Inc.

Ecovyst Inc. and subsidiaries is a leading provider of regenerated sulfuric acid, virgin sulfuric acid and sulfur dioxide and related derivatives, which we believe are essential to our customers’ operations and processes.... (truncated)rivatives in North America, serving key end uses including mining, water treatment and specialty chemical production. We also provide chemical waste handling and treatment services, as well as ex-situ catalyst activation services for the refining and petrochemical industry.

For more information, see our website at https://www.ecovyst.com.

Presentation of Non-GAAP Financial Measures

In addition to the results provided in accordance with U.S. generally accepted accounting principles (“GAAP”) throughout this press release, the Company has provided non-GAAP financial measures — Adjusted EBITDA, Adjusted Net Income, Free Cash Flow, Adjusted Free Cash Flow, Adjusted Diluted Income per share, Net Debt, Net Debt to Net Income Ratio and Net Debt Leverage Ratio (collectively, “Non-GAAP Financial Measures”) — which present results on a basis adjusted for certain items. The Company uses these Non-GAAP Financial Measures for business planning purposes and in measuring its performance relative to that of its competitors. The Company believes that these Non-GAAP Financial Measures are useful financial metrics to assess its operating performance from period-to-period by excluding certain items that the Company believes are not representative of its core business. These Non-GAAP Financial Measures are not intended to replace, and should not be considered superior to, the presentation of the Company’s financial results in accordance with GAAP. The use of the Non-GAAP Financial Measures terms may differ from similar measures reported by other companies and may not be comparable to other similarly titled measures. These Non-GAAP Financial Measures are reconciled from the respective measures under GAAP in the attached appendix.

Financial statements

Income Statement

Three months ended June 30, — (in millions, except share and per share amounts)

Three months ended June 30, – 2026Three months ended June 30, – 2025% ChangeSix months ended June 30, – 2026Six months ended June 30, – 2025% Change
Sales250176.142.0%464.9319.245.6%
Cost of goods sold200.2135.947.3%378.6259.945.7%
Gross profit49.840.223.9%86.359.345.5%
Selling, general and administrative expenses17.417.6-1.1%36.534.17.0%
Other operating expense, net136.891.2%17.910.472.1%
Operating income19.415.822.8%31.914.8115.5%
Interest expense, net3.58.5-58.8%6.616.8-60.7%
Debt modification and extinguishment costs1NM11
Other expense, net0.3-100.0%0.10.3-66.7%
Income (loss) from continuing operations before income taxes14.97112.9%24.2-3.3833.3%
Provision (benefit) for income taxes4.22110.0%7.8-0.2NM
Effective tax rate28.228.732.16.6
Net income (loss) from continuing operations10.75114.0%16.4-3.1629.0%
Net (loss) income from discontinued operations, net of tax-2.81-380.0%-4.25.5-176.4%
Net income7.9631.7%12.22.4408.3%
Earnings per share:Basic income (loss) per share - continuing operations0.10.040.15-0.03
Earnings per share:Diluted income (loss) per share - continuing operations0.10.040.15-0.03
Earnings per share:Basic (loss) income per share - discontinued operations-0.030.01-0.040.05
Earnings per share:Diluted (loss) income per share - discontinued operations-0.030.01-0.040.05
Earnings per share:Basic (loss) income per share0.070.050.110.02
Earnings per share:Diluted (loss) income per share0.070.050.110.02
Weighted average shares outstanding:Basic109,456,944116,232,528110,072,051116,745,476
Weighted average shares outstanding:Diluted110,839,894116,535,060111,312,917116,745,476

Income Statement

Three months ended June 30, — Appendix Table A-1: Reconciliation of Net Income (Loss) From Continuing Operations to Adjusted EBITDA from Continuing Operations (in millions)

Three months ended June 30, – 2026Three months ended June 30, – 2025% ChangeSix months ended June 30, – 2026Six months ended June 30, – 2025% Change
Reconciliation of net income (loss) from continuing operations to Adjusted EBITDA from continuing operationsNet income (loss) from continuing operations10.7516.4-3.1
Reconciliation of net income (loss) from continuing operations to Adjusted EBITDA from continuing operationsProvision (benefit) for income taxes4.227.8-0.2
Reconciliation of net income (loss) from continuing operations to Adjusted EBITDA from continuing operationsInterest expense, net3.58.56.616.8
Reconciliation of net income (loss) from continuing operations to Adjusted EBITDA from continuing operationsDepreciation and amortization19.61940.137.3
Reconciliation of net income (loss) from continuing operations to Adjusted EBITDA from continuing operationsEBITDA3834.570.950.8
Reconciliation of net income (loss) from continuing operations to Adjusted EBITDA from continuing operationsDebt modification and extinguishment costs111
Reconciliation of net income (loss) from continuing operations to Adjusted EBITDA from continuing operationsNet loss on asset disposals(a)2.30.32.60.4
Reconciliation of net income (loss) from continuing operations to Adjusted EBITDA from continuing operationsTransaction and other related costs(b)8.11.59.42.3
Reconciliation of net income (loss) from continuing operations to Adjusted EBITDA from continuing operationsEquity-based compensation2.52.85.95.3
Reconciliation of net income (loss) from continuing operations to Adjusted EBITDA from continuing operationsRestructuring, integration and business optimization expenses(c)0.411.21.2
Reconciliation of net income (loss) from continuing operations to Adjusted EBITDA from continuing operationsOther(d)0.81.81.92.2
Reconciliation of net income (loss) from continuing operations to Adjusted EBITDA from continuing operationsAdjusted EBITDA from continuing operations53.141.926.7%92.963.247.0%
Reconciliation of net income (loss) from continuing operations to Adjusted EBITDA from continuing operationsSales250176.142.0%464.9319.245.6%
Reconciliation of net income (loss) from continuing operations to Adjusted EBITDA from continuing operationsAdjusted EBITDA from continuing operations margin21.223.82019.8

Income Statement

Twelve months ended — Appendix Table A-1: Reconciliation of Net Income (Loss) From Continuing Operations to Adjusted EBITDA from Continuing Operations

Twelve months ended – June 30, 2026Twelve months ended – December 31, 2025% Change
Reconciliation of net income from continuing operations to Adjusted EBITDA from continuing operationsNet income from continuing operations25.86.3
Reconciliation of net income from continuing operations to Adjusted EBITDA from continuing operationsProvision for income taxes27.519.5
Reconciliation of net income from continuing operations to Adjusted EBITDA from continuing operationsInterest expense, net24.134.2
Reconciliation of net income from continuing operations to Adjusted EBITDA from continuing operationsDepreciation and amortization81.578.6
Reconciliation of net income from continuing operations to Adjusted EBITDA from continuing operationsEBITDA158.9138.6

Income Statement

Three months ended June 30, — (1) (in millions)

Three months ended June 30, – 2026 – Pre-tax amountSix months ended June 30, – 2026 – Pre-tax amountThree months ended June 30, – 2026 – Pre-tax amountSix months ended June 30, – 2026 – Pre-tax amountThree months ended June 30, – 2026 – Tax expense (benefit)Six months ended June 30, – 2026 – Tax expense (benefit)Three months ended June 30, – 2026 – Tax expense (benefit)Six months ended June 30, – 2026 – Tax expense (benefit)Three months ended June 30, – 2026 – After-tax amountSix months ended June 30, – 2026 – After-tax amountThree months ended June 30, – 2026 – After-tax amountSix months ended June 30, – 2026 – After-tax amountThree months ended June 30, – 2026 – Per share, basicSix months ended June 30, – 2026 – Per share, basicThree months ended June 30, – 2026 – Per share, basicSix months ended June 30, – 2026 – Per share, basicThree months ended June 30, – 2026 – Per share, dilutedSix months ended June 30, – 2026 – Per share, dilutedThree months ended June 30, – 2026 – Per share, dilutedSix months ended June 30, – 2026 – Per share, dilutedThree months ended June 30, – 2025 – Pre-tax amountSix months ended June 30, – 2025 – Pre-tax amountThree months ended June 30, – 2025 – Pre-tax amountSix months ended June 30, – 2025 – Pre-tax amountThree months ended June 30, – 2025 – Tax expense (benefit)Six months ended June 30, – 2025 – Tax expense (benefit)Three months ended June 30, – 2025 – Tax expense (benefit)Six months ended June 30, – 2025 – Tax expense (benefit)Three months ended June 30, – 2025 – After-tax amountSix months ended June 30, – 2025 – After-tax amountThree months ended June 30, – 2025 – After-tax amountSix months ended June 30, – 2025 – After-tax amountThree months ended June 30, – 2025 – Per share, basicSix months ended June 30, – 2025 – Per share, basicThree months ended June 30, – 2025 – Per share, basicSix months ended June 30, – 2025 – Per share, basicThree months ended June 30, – 2025 – Per share, dilutedSix months ended June 30, – 2025 – Per share, dilutedThree months ended June 30, – 2025 – Per share, dilutedSix months ended June 30, – 2025 – Per share, diluted
Net income from continuing operations14.94.210.70.10.17250.040.04
Debt modification and extinguishment costs10.20.80.010.01
Net loss on asset disposals(a)2.30.61.70.010.010.30.10.2
Transaction and other related costs(b)8.10.67.50.070.071.50.31.20.010.01
Equity-based compensation2.50.71.80.020.022.8-0.12.90.020.02
Restructuring, integration and business optimization expenses(c)0.40.10.310.30.70.010.01
Other(d)0.80.20.61.80.41.40.020.02
Adjusted Net Income(1)306.623.40.210.2114.4311.40.10.1
Weighted average shares outstanding109,456,944110,839,894116,232,528116,535,060
Net income (loss) from continuing operations24.27.816.40.150.15-3.3-0.2-3.1-0.03-0.03
Debt modification and extinguishment costs10.30.70.010.0110.20.80.010.01
Net loss on asset disposals(a)2.60.71.90.010.010.40.10.3

Balance Sheet

(in millions, except share and per share amounts)

June 30, 2026December 31, 2025
ASSETSCash and cash equivalents87.8197.2
ASSETSAccounts receivable, net112.985.3
ASSETSInventories, net4026.8
ASSETSDerivative assets1.91.3
ASSETSPrepaid and other current assets18.78.8
ASSETSTotal current assets261.3319.4
ASSETSProperty, plant and equipment, net534481.2
ASSETSGoodwill398.3326.7
ASSETSOther intangible assets, net135.559.3
ASSETSRight-of-use lease assets53.137.9
ASSETSOther long-term assets38.536.5
ASSETSTotal assets1,420.71,261
LIABILITIESAccounts payable7448
LIABILITIESOperating lease liabilities—current13.29.5
LIABILITIESAccrued liabilities66.363.3
LIABILITIESTotal current liabilities153.5120.8
LIABILITIESLong-term debt493392.6
LIABILITIESDeferred income taxes146113.3
LIABILITIESOperating lease liabilities—noncurrent40.228.7
LIABILITIESOther long-term liabilities1.12.1
LIABILITIESTotal liabilities833.8657.5
EQUITYCommon stock ($0.01 par); authorized shares 450,000,000; issued shares 140,872,846 and 140,872,846 on June 30, 2026 and December 31, 2025, respectively; outstanding shares 109,468,398 and 111,805,102 on June 30, 2026 and December 31, 2025, respectively1.41.4
EQUITYAdditional paid-in capital1,105.81,108.5
EQUITYAccumulated deficit-236.5-248.6
EQUITYTreasury stock, at cost; shares 31,404,448 and 29,067,744 on June 30, 2026 and December 31, 2025, respectively-289.3-261.1
EQUITYAccumulated other comprehensive income5.53.3
EQUITYTotal equity586.9603.5
EQUITYTotal liabilities and equity1,420.71,261

Cash Flow

Six months ended June 30, — CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (in millions)

Six months ended June 30, – 2026Six months ended June 30, – 2025
Net income12.22.4
Net loss (income) from discontinued operations4.2-5.5
Net income (loss) from continuing operations16.4-3.1
Adjustments to reconcile net income to net cash provided by operating activities:Depreciation34.732
Adjustments to reconcile net income to net cash provided by operating activities:Amortization5.45.3
Adjustments to reconcile net income to net cash provided by operating activities:Amortization of deferred financing costs and original issue discount0.40.6
Adjustments to reconcile net income to net cash provided by operating activities:Deferred income tax provision2.61.7
Adjustments to reconcile net income to net cash provided by operating activities:Net loss on asset disposals2.60.4
Adjustments to reconcile net income to net cash provided by operating activities:Stock compensation5.95.3
Adjustments to reconcile net income to net cash provided by operating activities:Other, net-3.1-0.6
Working capital changes that provided (used) cash:Receivables-13.6-19.3
Working capital changes that provided (used) cash:Inventories-10.70.4
Working capital changes that provided (used) cash:Prepaids and other current assets-3.2-1.1
Working capital changes that provided (used) cash:Accounts payable208.8
Working capital changes that provided (used) cash:Accrued liabilities-2.2-5.1
Working capital changes that provided (used) cash:Net cash provided by operating activities, continuing operations55.225.3
Working capital changes that provided (used) cash:Net cash (used in) provided by operating activities, discontinued operations-3.918
Working capital changes that provided (used) cash:Net cash provided by operating activities51.343.3
Cash flows from investing activities:Purchases of property, plant and equipment-44.8-39.1
Cash flows from investing activities:Business combinations-178.5-41.3
Cash flows from investing activities:Net cash used in investing activities, continuing operations-223.3-80.4
Cash flows from investing activities:Net cash used in investing activities, discontinued operations-10.4
Cash flows from investing activities:Net cash used in investing activities-223.3-90.8

Cash Flow

Six months ended June 30, — Appendix Table A-3: Adjusted Free Cash Flow (in millions)

Six months ended June 30, – 2026Six months ended June 30, – 2025
Net cash provided by operating activities51.343.3
Less:Purchases of property, plant and equipment(1)-44.8-49.5
Less:Free Cash Flow(2)6.5-6.2
Adjustments to free cash flow:Cash paid for debt financing costs11
Adjustments to free cash flow:Cash paid for costs related to acquisitions4.22.8
Adjustments to free cash flow:Cash paid for costs related to the segment disposal1.1
Full release

Note on Forward-Looking Statements

Some of the information contained in this press release constitutes “forward-looking statements.” Forward-looking statements can be identified by words such as “anticipates,” “intends,” “plans,” “seeks,” “believes,” “estimates,” “expects,” “projects” and similar references to future periods. Forward-looking statements are based on our current expectations and assumptions regarding our business, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict. Examples of forward-looking statements include, but are not limited to, statements regarding our future results of operations, financial condition, capital expenditure projects, liquidity, prospects, growth, strategies, capital allocation program (including the stock repurchase program), product and service offerings, expected demand trends, the integration of our recently-acquired Calabrian business and the expected financial contributions relating to such acquisition and our 2026 financial outlook. Our actual results may differ materially from those contemplated by the forward-looking statements. We caution you, therefore, against placing any undue reliance on any of these forward-looking statements. They are neither statements of historical fact nor guarantees or assurances of future performance. Important factors that could cause actual results to differ materially from those in the forward-looking statements include, but are not limited to, regional, national or global political, economic, business, competitive, market and regulatory conditions, including the enactment, schedule and impact of tariffs and trade disputes, currency exchange rates, military conflicts, the effects of inflation, our ability to successfully integrate the Calabrian sulfur dioxide and sulfur derivatives business into our business and realize the benefits of that acquisition and other factors, including those described in the sections titled “Risk Factors” and “Management’s Discussion & Analysis of Financial Condition and Results of Operations” in our filings with the SEC, which are available on the SEC’s website at www.sec.gov. These forward-looking statements speak only as of the date of this release. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by applicable law.

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Ecovyst earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.